Topical Corticosteroids and Type 2 Diabetes Mellitus: A Critical Appraisal.

Topical Corticosteroids and Type 2 Diabetes Mellitus: A Critical Appraisal.
Br J Dermatol. 2019 Dec 28;:
Authors: Wong L, Tadrous M
Abstract
Topical corticosteroids are widely used to treat inflammatory or pruritic skin conditions. The impact of systemic absorption of topical corticosteroids on the risk of hyperglycemia, and subsequent type 2 diabetes is unclear. Andersen et al. aimed to determine if topical corticosteroid use for psoriasis and eczema,1 which affect 2-3% and 2-8% of adults worldwide, respectively, is associated with an increased risk of newly-diagnosed type 2 diabetes.2,3.
PMID: 31883374 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - December 27, 2019 Category: Dermatology Authors: Wong L, Tadrous M Tags: Br J Dermatol Source Type: research